We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Progression to Impaired Glucose Tolerance and Type 2 Diabetes in the Korean People-based KNDP Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01034826
Recruitment Status : Completed
First Posted : December 18, 2009
Last Update Posted : June 9, 2010
Information provided by:

Study Description
Brief Summary:
Impaired glucose tolerance is a metabolic state between normal glucose homeostasis and diabetes. Previously, prospective studies have shown higher progression rates from IGT to diabetes in other country. But There is no prospective-multicenter based reports in Korea. Therefore, the purpose of this study is to estimate the progression rates to impair glucose regulation and diabetes in the Korean population-based Korea national Diabetes program.

Condition or disease
Impaired Glucose Tolerance Diabetes

Study Design

Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Case-Only
Time Perspective: Prospective
Study Start Date : February 2007
Primary Completion Date : December 2009
Study Completion Date : May 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

life style modification
everyone in this study was advised about their life style, diet, exercise habits.

Outcome Measures

Primary Outcome Measures :
  1. fasting serum glucose, fasting plasma insulin,post prandial serum glucose, post prandial plasma insulin, hbA1c [ Time Frame: year ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patients who vist the endocrinology department due to impaired fasting glucose or impaired glucose tolerance, or both.

Inclusion Criteria:

  • fastic serum glucose >100 and/or pp2 serum glucose <200

Exclusion Criteria:

  • known diabetes
  • organ failure(For example, liver, kidney)
  • known malignancy
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Korea university Guro Hospital Endocrinology department, Korea university
ClinicalTrials.gov Identifier: NCT01034826     History of Changes
Other Study ID Numbers: KNDP IGT study
First Posted: December 18, 2009    Key Record Dates
Last Update Posted: June 9, 2010
Last Verified: December 2009

Keywords provided by Korea University Guro Hospital:
NGT, IGT, diabetes

Additional relevant MeSH terms:
Glucose Intolerance
Glucose Metabolism Disorders
Metabolic Diseases